Lymph Nodes in the Presence of Apoptotic Potent Antitumor CD4+ T Cells in Draining CD40 Ligand Promotes Priming of Fully

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• CD4+ T Lymphocytes with Constitutive CD40 Ligand in Preautoimmune (NZB × NZW)F1 Lupus-Prone Mice: Phenotype and Possible Role in Autoreactivity1

  2000cited by this paper
• Macrophage Inflammatory Protein 3α Is Expressed at Inflamed Epithelial Surfaces and Is the Most Potent Chemokine Known in Attracting Langerhans Cell Precursors

  2000cited by this paper
• Host CD40 Ligand Deficiency Induces Long-Term Allograft Survival and Donor-Specific Tolerance in Mouse Cardiac Transplantation But Does Not Prevent Graft Arteriosclerosis1

  2000cited by this paper
• Cd40–Cd40 Ligand Interactions in Vivo Regulate Migration of Antigen-Bearing Dendritic Cells from the Skin to Draining Lymph Nodes

  2000cited by this paper
• The Induction of Tolerance by Dendritic Cells That Have Captured Apoptotic Cells

  2000cited by this paper
• Dendritic Cell Migration Controlled by α1b-Adrenergic Receptors1

  2000cited by this paper
• Cross-Presentation of Tumor Antigens to Effector T Cells Is Sufficient to Mediate Effective Immunotherapy of Established Intracranial Tumors1

  2000cited by this paper
• The chemokine receptor switch paradigm and dendritic cell migration: its significance in tumor tissues

  2000cited by this paper
• Consequences of cell death: exposure to necrotic tumor cells

  2000cited by this paper
• Successful adoptive immunotherapy of murine poorly immunogenic tumor with specific effector cells generated from gene-modified tumor-primed lymph node cells.

  1999cited by this paper
• CD8 T cell ignorance or tolerance to islet antigens depends on antigen dose.

  1999cited by this paper
• Impaired ability of MHC class II-/- dendritic cells to provide tumor protection is rescued by CD40 ligation.

  1999cited by this paper
• Transfection of immature murine bone marrow-derived dendritic cells with the granulocyte-macrophage colony-stimulating factor gene potently enhances their in vivo antigen-presenting capacity.

  1999cited by this paper
• Chemokines and cell migration in secondary lymphoid organs.

  1999cited by this paper
• Natural adjuvants: Endogenous activators of dendritic cells

  1999cited by this paper
• Effects of TGF-β on the immune system: implications for cancer immunotherapy

  1999cited by this paper
• Immune defects observed in patients with primary malignant brain tumors.

  1999cited by this paper
• Help for cytotoxic-T-cell responses is mediated by CD40 signalling

  1998cited by this paper
• Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

  1998cited by this paper
• T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions

  1998cited by this paper
• Efficient Presentation of Phagocytosed Cellular Fragments on the Major Histocompatibility Complex Class II Products of Dendritic Cells

  1998cited by this paper
• Purification of L-selectin(low) cells promotes the generation of highly potent CD4 antitumor effector T lymphocytes.

  1998cited by this paper
• Dendritic cells require maturation via CD40 to generate protective antitumor immunity.

  1998cited by this paper
• Immature Dendritic Cells Phagocytose Apoptotic Cells via αvβ5 and CD36, and Cross-present Antigens to Cytotoxic T Lymphocytes

  1998cited by this paper
• Processing of engulfed apoptotic bodies yields T cell epitopes.

  1997cited by this paper
• Induction of a CD8+ Cytotoxic T Lymphocyte Response by Cross-priming Requires Cognate CD4+ T Cell Help

  1997cited by this paper
• CD4+ T Cell Help Impairs CD8+ T Cell Deletion Induced by Cross-presentation of Self-Antigens and Favors Autoimmunity

  1997cited by this paper
• Immunosuppressive effects of apoptotic cells

  1997cited by this paper
• Interleukin-10 as a possible mediator of immunosuppressive effect in patients with squamous cell carcinoma of the head and neck

  1997cited by this paper
• The Macrophage Scavenger Receptor Type A Is Expressed by Activated Macrophages and Protects the Host Against Lethal Endotoxic Shock

  1997cited by this paper
• Class I–restricted Cross-Presentation of Exogenous Self-Antigens Leads to Deletion of Autoreactive CD8+ T Cells

  1997cited by this paper
• Adoptive immunotherapy with tumor-specific T lymphocytes generated from cytokine gene-modified tumor-primed lymph node cells.

  1996cited by this paper
• In vitro immunization of naive mouse B cells: establishment of IgM secreting hybridomas specific for souble protein or hapten from B cells cultured on CD40 ligand transfected mouse fibroblasts.

  1996cited by this paper
• Treatment of intracranial tumors by systemic transfer of superantigen-activated tumor-draining lymph node T cells.

  1996cited by this paper
• Isolation based on L-selectin expression of immune effector T cells derived from tumor-draining lymph nodes.

  1996cited by this paper
• CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response

  1996cited by this paper
• Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection.

  1996cited by this paper
• A subset of CD4+ memory T cells contains preformed CD40 ligand that is rapidly but transiently expressed on their surface after activation through the T cell receptor complex

  1995cited by this paper
• Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens.

  1994cited by this paper
• Stimulation of tumor-draining lymph node cells with superantigenic staphylococcal toxins leads to the generation of tumor-specific effector T cells.

  1994cited by this paper
• Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2.

  1994cited by this paper
• Suppression of Anti‐tumor CD4+ T Cell Responsiveness in the Tumor‐bearing State and Its Recovery in in vitro Culture Free of Tumor Burden

  1993cited by this paper
• The role of the CD28 receptor during T cell responses to antigen.

  1993cited by this paper
• Tumor-bearing mice exhibit a progressive increase in tumor antigen-presenting cell function and a reciprocal decrease in tumor antigen-responsive CD4+ T cell activity.

  1992cited by this paper
• Defective presentation of endogenous antigens by a murine sarcoma. Implications for the failure of an anti-tumor immune response.

  1991cited by this paper
• Specific adoptive immunotherapy mediated by tumor-draining lymph node cells sequentially activated with anti-CD3 and IL-2.

  1991cited by this paper
• Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization.

  1990cited by this paper
• The proteins encoded by the VpreB and lambda 5 pre-B cell-specific genes can associate with each other and with mu heavy chain

  1990cited by this paper
• Down-regulation of homing receptors after T cell activation.

  1988cited by this paper
• Adoptive immunotherapy of newly induced murine sarcomas.

  1985cited by this paper
• Brief Definitive Report Major Histocompatibility Complex Class I–restricted Cross-presentation Is Biased towards High Dose Antigens and Those Released during Cellular Destruction

  year unknowncited by this paper

• No citing papers are available for this paper.